Specifically, overall stigma score decreased by –0.15 +/– 0.028 points for each additional week following KS diagnosis after accounting for random intercepts by participant and fixed‐affects for sex, age, KS stage at the time of diagnosis, death at the end of the study period and baseline CD4 count (95% CI: –0.21, –0.098; p < 0.001) (Supplement A, Table S1). The gene discussed is CD4; the disease is Kaposi's sarcoma.